Aydemir, Sezinİşlek, AliNepesov, SerdarYaman, YöntemBaysoy, GökhanBeşer, Ömer FarukÇullu Çokuğraş, FügenBarış, SafaKarakoç Aydıner, ElifÇokuğraş, HalukHubrack, Satanay Z.Kendir Demirkol, YaseminLo, BerniceKıykım, AyçaÖzen, Ahmet2021-10-142021-10-142021Aydemir, S., İşlek, A., Nepesov, S., Yaman, Y., Baysoy, G., Beşer, Ö. F. ... Özen, A. (2021). Inflammatory bowel disease and guillain barre syndrome in FCHO1 deficiency. Journal of Clinical Immunology, 41(6), 1406-1410. https://dx.doi.org/10.1007/s10875-021-01042-20271-91421573-2592https://dx.doi.org/10.1007/s10875-021-01042-2https://hdl.handle.net/20.500.12511/8450To the Editor: FCH And Mu Domain Containing Endocytic Adaptor 1 (FCHO1) gene encodes a protein that plays a critical role in clathrin-mediated endocytosis, a biological process that maintains cellular functions in signaling, nutrient- and growth factor- uptake, and diferentiation [1–3]. Recently, biallelic mutations in FCHO1 were linked to a combined immunodefciency that is characterized by recurrent infections caused by bacteria, viruses, mycobacteria, fungi, T cell lymphopenia, and hypogammaglobulinemia [4, 5].eninfo:eu-repo/semantics/embargoedAccessFCHO1 DeficiencyGuillain Barre SyndromeBowel DiseaseEditorial4161406141010.1007/s10875-021-01042-2Q1Q1